期刊文献+

肥厚梗阻型心肌病化学消融术酒精用量对术后早期血流动力学和心脏重构的影响 被引量:1

Effects of low-dose alcohol in pecutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on early hemodynamics and left ventricular remodeling
下载PDF
导出
摘要 目的:探讨经皮室间隔心肌化学消融术(PTSMA)最适酒精使用剂量。方法:连续选择2007年1月~2010年12月在本院接受低剂量酒精(≤2.0 ml)消融的肥厚梗阻型心肌病(HOCM)患者10例;按1∶2配比的病例对照研究,选择2000年1月~2006年12月接受较大剂量酒精(>2.0 ml)消融治疗的患者20例作为历史对照组,分别评估两种治疗方案对术后早期血流动力学和心脏重构的影响。结果:低剂量和对照组术后即刻[(28.0±8.8)mmHg和(27.5±7.2)mmHg]、术后3个月[(29.5±6.6)mmHg和(28.1±5.0)mmHg]的左心室流出道压力阶差(LVOTPG)均较基线时[(69.9±13.1)mmHg和(70.6±13.4)mmHg]显著性下降(P<0.01),术后室间隔厚度明显减小(P<0.01),左心室舒张末内径无变化;而两组间术后即刻、术后3个月LVOTPG水平及下降幅度均无差异(P>0.05);相关分析显示,酒精用量分别与术后即刻LVOTPG以及术后3个月LVOTPG、室间隔厚度和左室舒张末内径等变化无相关性(P>0.05)。结论:小剂量酒精消融同样导致术后早期血流动力学和心脏结构的改善。 Objective: To determine the effects of various doses of alcohol in pecutaneous transluminal septal myocardial ablation(PTSMA) for obstructive hypertrophic cardiomyopathy(HOCM).Methods: A 1∶2 matched case-control study was performed in our hospital.Ten consecutive patients with HOCM were assigned to receive small dose of alcohol(≤2.0 ml),and they were compared with 20 cases receiving standard doses( 2.0 ml).Early results of hemodynamic changes and left ventricular remodeling were determined invasively and by echocardiography before and after PTSMA.Results: In low-dose alcohol group,left ventricular outflow tract pressure gradient(LVOTPG) was(28.0 ± 8.8) mmHg immediately after PTSMA(P 0.01),and(29.5 ± 6.6) mmHg at 3 months(P 0.01),versus(69.9 ± 13.1) mmHg before the procedure.In standard group,LVOTPG was(27.5 ± 7.2) mmHg immediately and(28.1 ± 5.0) mmHg at 3 months after PTSMA(P 0.01),vs(70.6 ± 13.4) mmHg before the procedure.The thickness of interventricular septum(IVS) was significantly decreased at 3 months post-PTSMA in both groups(P 0.01).However,there were no significant differences in hemodynamic and morphologic changes between the 2 groups after PTSMA.No significant correlations were identified between the volume of ethanol injected and early hemodynamic,morphologic variables immediately or at 3 months after PTSMA either in low or standard dose of alcohol.Conclusion: Low-dose of alcohol was able to achieve the desirable degree of LVOTPG reduction and left ventricular remodeling in PTSMA.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第10期1440-1443,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省兴卫工程重点学科开放课题(XK05200902 XK05200903)
关键词 经皮室间隔心肌化学消融术 左心室流出道压力阶差 酒精用量 pecutaneous transluminal septal myocardial ablation 1eft ventricular outflow tract pressure gradient low-dose alcohol
  • 相关文献

参考文献19

二级参考文献43

  • 1JIANG Teng-yong,WU Xue-si,HAN Zhi-hong,JIA Chang-qi,MI Hong-zhi,GAO Yue-chun,ZHANG Xiao-ling.Myocardial condition after transcoronary ablation predicts the curative effect in patients with hypertrophic obstructive cardiomyopathy[J].Chinese Medical Journal,2006(3):246-249. 被引量:1
  • 2Boekstegers P, Steinbigler P, Molnar A, et al. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol,2001, 38:846-853.
  • 3Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy:resuhs with respect to intraprocedural myocardial contrast echocardiography. Circulation, 1998,98:2415-2421.
  • 4Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation, 2004, 109:452-456.
  • 5Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol, 2006,19:319-327.
  • 6Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol,2001, 38:1994-2000.
  • 7Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol,2001, 38 : 1701-1706.
  • 8Firoozi S, Elliott PM, Sharma 5, et at. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical haemodynamic and exercise outcomes. Eur Heart J, 2002,23: 1617-1624.
  • 9van der Lee C, ten Cate FJ, Geleijnse MC, et al. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation ,2005, 112:482-488.
  • 10Maron B J, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coil Cardiol, 2003,42 : 1687-1713.

共引文献58

同被引文献11

  • 1MARON B J. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic eardiomyopathy [J]. Circulation, 2010,121:445-456.
  • 2R1GOPOULOS A G, SEGGEWISS H. A decade of percutaneous septal ablation in hypertrophic cardio- myopathy[J]. Circ J ,2011,75 :28-37.
  • 3VESELKA J, ZEMANEK D, TOMASOV P, et al. Complications of low-dose, echo guided alcohol septal ablation[J]. Catheter Cardiovasc Interv, 2010,75 : 546 -550.
  • 4TEN CATE FJ, SOLIMAN O I, MICHELS M, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopa- thy~ a word of eaution[J]. Circ Heart Fail, 2010,3 : 362-369.
  • 5VESELKA J, TOMASOV P, ZEMANEK D. Long- term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomy- opathy: a randomized study with a follow-up up to 11 years[J]. CanJ Cardiol,2011,27:763-767.
  • 6LEONARDI R A, KRANSDORF E P, SIMEL D L, etal. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: compara- tive rates of overall mortality and sudden cardiac death after treatment [J]. Circ Cardiovasc Interv, 2010,3:97-104.
  • 7AGARWAL S, TUZCU E M, DESAI M Y, et al. Updated recta-analysis of septal alcohol ablation ver sus myectomy for hypertrophic cardiomyopathy[J]. J Am Coil Cardiol, 2010,55 : 823 - 834.
  • 8KUHN H J. Optimizing catheter-based therapy of hy pertrophic obstructive cardiomyopathy: does alcohol dose matter? [J]. CanJ Cardiol,2011,27 :668-670.
  • 9VESEI.KA J, PROCHAZKOVA S, DUCHONOVA R, et al. Alcohol septal ablation for hypertrophic ob structive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome[J]. Catheter Cardiovasc Interv, 2004,63:231-235.
  • 10KUHN H, LAWRENZ T, I.IEDER F, et al. Survival af-ter transcoronary ablation of septal hypertrophy in hyper- trophic obstructive cardiomyopathy (TASH): a 10 year experience[J]. Clin Res Cardiol, 2008,97 : 234- 243.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部